Although it is curable, tuberculosis remains one of the most frequent causes of pleural
effusions on a global scale, especially in developing countries. Tuberculous pleural effusion …

Multidrug-resistant (MDR) tuberculosis (TB) is a threat to global TB control, as suboptimal
and poorly tolerated treatment options have resulted in largely unfavourable outcomes for …

The WHO treatment guidelines for drug-resistant tuberculosis, 2016 update aims to support
health professionals worldwide to respond to the continued challenge posed by …

Bedaquiline, a diarylquinoline, improved cure rates when added to a multidrug-resistant
tuberculosis (MDR-TB) treatment regimen in a previous placebo-controlled, phase 2 trial …

The importance of adequately managing multidrug-resistant (MDR) and extensively drug-
resistant (XDR) tuberculosis (TB) cases for TB control and elimination are underlined in the …

The emergence of drug-resistant strains of Mycobacterium tuberculosis is a challenge to
global tuberculosis (TB) control. Although culture-based methods have been regarded as …

Background Treatment of drug-susceptible tuberculosis (TB) conducted under strong
national TB programs (NTPs) using standard 4-drug therapy and directly observed therapy …

Tuberculosis has a high morbidity and mortality worldwide. Mycobacterium tuberculosis
(Mtb) has a complex pathophysiology; it is an aerobic bacillus capable of surviving in …

To identify factors associated with loss to follow-up during treatment for multidrug-resistant
(MDR) tuberculosis (TB) in the Philippines, we conducted a case–control study of adult …

Background. Resistance to second-line drugs develops during treatment of multidrug-
resistant (MDR) tuberculosis, but the impact on treatment outcome has not been determined …